Summary statement on screening for prostate cancer in Europe

• Published in: International journal of cancer Vol. 142; no. 4; pp. 741 - 746
• Main Authors: Heijnsdijk, Eveline A.M., Bangma, Chris H., Borràs, Josep M., de Carvalho, Tiago M., Castells, Xavier, Eklund, Martin, Espinàs, Josep A., Graefen, Markus, Grönberg, Henrik, Lansdorp‐Vogelaar, Iris, Leeuwen, Pim J. van, Nelen, Vera, Recker, Franz, Roobol, Monique J., Vandenbulcke, Pieter, de Koning, Harry J.
• Format: Journal Article
• Language: English
• Published: United States Wiley Subscription Services, Inc 15.02.2018
• Subjects: Antigens; Cancer; Cancer screening; Feasibility studies; Magnetic resonance imaging; mass‐screening; Medical research; Medical screening; Medicin och hälsovetenskap; Mortality; Prostate cancer; Prostate-specific antigen; PSA; Surveillance; Tumors; mortality; prostate cancer; mass-screening; PSA

The European Randomised Study of Screening for Prostate Cancer (ERSPC) showed that Prostate‐Specific Antigen (PSA) based screening results in a significant prostate cancer mortality reduction. Although there are concerns on overdiagnosis and overtreatment, it has been shown that the benefits can out...